Early-life exposure to lead (Pb) alters the expression of microrna that target proteins associated with Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 51, Issue 4, 2016, Pages 1257-1264

  Masoud, Anwar M ^a,b   Bihaqi, Syed W ^c   Machan, Jason T ^d   Zawia, Nasser H ^a   Renehan, William E ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b THAMAR UNIVERSITY   (Yemen)

^c UNIVERSITY OF HAIL   (Saudi Arabia)

^d BROWN UNIVERSITY   (United States)

Author keywords

Amyloid protein precursor; lead; MiRNA; neurodegeneration; tau

Indexed keywords

LEAD; MICRORNA; MICRORNA 106B; MICRORNA 124; MICRORNA 132; MICRORNA 148A; MICRORNA 29B; MICRORNA 34C; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; AMYLOID PRECURSOR PROTEIN; MESSENGER RNA;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST MILK; CONTROLLED STUDY; EXPOSURE; FEMALE; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; POSTNATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN METHYLATION; PROTEIN RNA BINDING; QUANTITATIVE ANALYSIS; AGE; ANIMAL; C57BL MOUSE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEWBORN; PREGNANCY;

AGE FACTORS; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LEAD; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; PREGNANCY; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR;

EID: 84964903998     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-151018     Document Type: Article

References (48)

1. Rosenthal SL, Kamboh MI (2014) Late-onset Alzheimer's disease genes and the potentially implicated pathways. Curr Genet Med Rep 2, 85 - 101.
2. Gusareva ES, Carrasquillo MM, Bellenguez C, Cuyvers E, Colon S, Graff-Radford NR, Petersen RC, Dickson DW, Mahachie John JM, Bessonov K, Van Broeckhoven C, Harold D, Williams J, Amouyel P, Sleegers K, Ertekin-Taner N, Lambert JC, Van Steen K (2014) Genome-wide association interaction analysis for Alzheimer's disease. Neurobiol Aging 35, 2436 - 2443.
3. Guerreiro R, Bras J, Hardy J (2013) SnapShot: Genetics of Alzheimer's disease. Cell 155, 968. e1.
4. Karch CM, Goate AM (2014) Alzheimer's disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry 77, 43 - 51.
5. Humphries C, Kohli MA (2014) Rare variants and transcriptomics in Alzheimer disease. Curr Genet Med Rep 2, 75 - 84.
6. Lunnon K, Mill J (2013) Epigenetic studies in Alzheimer's disease: Current findings, caveats, and considerations for future studies. Am J Med Genet B Neuropsychiatr Genet 162b, 789 - 799.
7. Graff J, Kim D, Dobbin MM, Tsai LH (2011) Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol Rev 91, 603 - 649.
8. Modgil S, Lahiri DK, Sharma VL, Anand A (2014) Role of early life exposure and environment on neurodegeneration: Implications on brain disorders. Transl Neurodegener 3, 9
9. Basha MR, Wei W, Bakheet SA, Benitez N, Siddiqi HK, Ge YW, Lahiri DK, Zawia NH (2005) The fetal basis of amyloidogenesis: Exposure to lead and latent overexpression of amyloid precursor protein and beta-amyloid in the aging brain. J Neurosci 25, 823 - 829.
10. Zawia NH, Sharan R, Brydie M, Oyama T, Crumpton T (1998) Sp1 as a target site for metal-induced perturbations of transcriptional regulation of developmental brain gene expression. Brain Res Dev Brain Res 107, 291 - 298.
11. Atkins DS, Basha MR, Zawia NH (2003) Intracellular signaling pathways involved in mediating the effects of lead on the transcription factor Sp1. Int J Dev Neurosci 21, 235 - 244.
12. Bihaqi SW, Bahmani A, Adem A, Zawia NH (2014) Infantile postnatal exposure to lead (Pb) enhances tau expression in the cerebral cortex of aged mice: Relevance to AD. Neurotoxicology 44, 114 - 120.
13. Bihaqi SW, Bahmani A, Subaiea GM, Zawia NH (2013) Infantile exposure to lead and late-age cognitive decline: Relevance to AD. Alzheimers Dement 10, 187 - 195.
14. Wu J, Basha MR, Brock B, Cox DP, Cardozo-Pelaez F, McPherson CA, Harry J, Rice DC, Maloney B, Chen D, Lahiri DK, Zawia NH (2008) Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): Evidence for a developmental origin and environmental link for AD. J Neurosci 28, 3 - 9.
15. Bihaqi SW, Zawia NH (2013) Enhanced taupathy and AD-like pathology in aged primate brains decades after infantile exposure to lead (Pb). Neurotoxicology 39, 95 - 101.
16. Bihaqi SW, Huang H, Wu J, Zawia NH (2011) Infant exposure to lead (Pb) and epigenetic modifications in the aging primate brain: Imlications for Alzheimer's disease. J Alzheimers Dis 27, 819 - 833.
17. Safe S, Imanirad P, Sreevalsan S, Nair V, Jutooru I (2014) Transcription factor Sp1, also known as specificity protein 1 as a therapeutic target. Expert Opin Ther Targets 18, 759 - 769.
18. Wong HK, Veremeyko T, Patel N, Lemere CA, Walsh DM, Esau C, Vanderburg C, Krichevsky AM (2013) De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. Hum Mol Genet 22, 3077 - 3092.
19. Kishikawa S, Murata T, Kimura H, Shiota K, Yokoyama KK (2002) Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins. Eur J Biochem 269, 2961 - 2970.
20. Jinawath A, Miyake S, Yanagisawa Y, Akiyama Y, Yuasa Y (2005) Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. Biochem J 385, 557 - 564.
21. Huang SK, Scruggs AM, Donaghy J, McEachin RC, Fisher AS, Richardson BC, Peters-Golden M (2012) Prostaglandin E(2) increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression. FASEB J 26, 3703 - 3714.
22. Safe S, Abdelrahim M (2005) Sp transcription factor family and its role in cancer. Eur J Cancer 41, 2438 - 2448.
23. Schonrock N, Gotz J (2012) Decoding the non-coding RNAs in Alzheimer's disease. Cell Mol Life Sci 69, 3543 - 3559.
24. Goodall EF, Heath PR, Bandmann O, Kirby J, Shaw PJ (2013) Neuronal dark matter: The emerging role of microRNAs in neurodegeneration. Front Cell Neurosci 7, 178.
25. Hsu SD, Tseng YT, Shrestha S, Lin YL, Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, Jian TY, Lin FM, Chang TH, Weng SL, Liao KW, Liao IE, Liu CC, Huang HD (2014) miRTarBase update 2014: An information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res 42, D78 - D85.
26. Bihaqi SW, Bahmani A, Subaiea GM, Zawia NH (2014) Infantile exposure to lead and late-age cognitive decline: Relevance to AD. Alzheimers Dement 10, 187 - 195.
27. Mardia KV, Kent JT, Bibby JM (1979), Multivariate Analysis, Academic Press.
28. O'Brien RG (1979) A general ANOVA method for robust tests of additive models for variances. J Am Statistical Assn 74, 877 - 880.
29. Hebert SS, Horre K, Nicolai L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B (2009) MicroRNA regulation of Alzheimer's Amyloid precursor protein expression. Neurobiol Dis 33, 422 - 428.
30. Wu H, Huang M, Lu M, Zhu W, Shu Y, Cao P, Liu P (2013) Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Cancer Chemother Pharmacol 71, 1159 - 1171.
31. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769 - 773.
32. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G (2009) MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113, 6411 - 6418.
33. Takada S, Berezikov E, Choi YL, Yamashita Y, Mano H (2009) Potential role of miR-29b in modulation of Dnmt3a and Dnmt3b expression in primordial germ cells of female mouse embryos. RNA 15, 1507 - 1514.
34. Jia LF, Huang YP, Zheng YF, Lyu MY, Wei SB, Meng Z, Gan YH (2014) miR-29b suppresses proliferation, migration, and invasion of tongue squamous cell carcinoma through PTEN-AKT signaling pathway by targeting Sp1. Oral Oncol 50, 1062 - 1071.
35. Li J, Du S, Sheng X, Liu J, Cen B, Huang F, He Y (2016) MicroRNA-29b inhibits endometrial fibrosis by regulating the Sp1-TGF-beta1/Smad-CTGF axis in a rat model. Reprod Sci 23, 386 - 394.
36. Villa C, Ridolfi E, Fenoglio C, Ghezzi L, Vimercati R, Clerici F, Marcone A, Gallone S, Serpente M, Cantoni C, Bonsi R, Cioffi S, Cappa S, Franceschi M, Rainero I, Mariani C, Scarpini E, Galimberti D (2013) Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with Alzheimer's disease. J Alzheimers Dis 35, 487 - 494.
37. Yu J, Luo H, Li N, Duan X (2015) Suppression of Type I collagen expression by miR-29b Via PI3K, Akt, and Sp1 pathway, part ii: An in vivo investigation. Invest Ophthalmol Vis Sci 56, 6019 - 6028.
38. Pan W, Zhu S, Yuan M, Cui H, Wang L, Luo X, Li J, Zhou H, Tang Y, Shen N (2010) MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4 T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 184, 6773 - 6781.
39. Gailhouste L, Gomez-Santos L, Hagiwara K, Hatada I, Kitagawa N, Kawaharada K, Thirion M, Kosaka N, Takahashi RU, Shibata T, Miyajima A, Ochiya T (2013) miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells. Hepatology 58, 1153 - 1165.
40. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA (2010) MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.705-714, 714.e. Gastroenterology 138, 705 - 714. 714.e1-4.
41. Alvarez-Saavedra M, Antoun G, Yanagiya A, Oliva-Hernandez R, Cornejo-Palma D, Perez-Iratxeta C, Sonenberg N, Cheng HY (2011) miRNA-132 orchestrates chromatin remodeling and translational control of the circadian clock. Hum Mol Genet 20, 731 - 751.
42. Basha MR, Murali M, Siddiqi HK, Ghosal K, Siddiqi OK, Lashuel HA, Ge YW, Lahiri DK, Zawia NH (2005) Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation. FASEB J 19, 2083 - 2084.
43. Dosunmu R, Wu J, Adwan L, Maloney B, Basha MR, McPherson CA, Harry GJ, Rice DC, Zawia NH, Lahiri DK (2009) Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice. J Alzheimers Dis 18, 211 - 230.
44. Lahiri DK, Maloney B, Basha MR, Ge YW, Zawia NH (2007) How and when environmental agents and dietary factors affect the course of Alzheimer's disease: The "LEARn" model (latent early-life associated regulation) may explain the triggering of AD. Curr Alzheimer Res 4, 219 - 228.
45. Lahiri DK, Maloney B, Zawia NH (2009) The LEARn model: An epigenetic explanation for idiopathic neurobiological diseases. Mol Psychiatry 14, 992 - 1003.
46. Acunzo M, Romano G, Wernicke D, Croce CM (2014) MicroRNA and cancer-a brief overview. Adv Biol Regul 57, 1 - 9.
47. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10, 704 - 714.
48. Garofalo M, Leva GD, Croce CM (2014) MicroRNAs as anti-cancer therapy. Curr Pharm Des 20, 5328 - 5335.